Entry |
|
Symbol |
ADCY3
|
Name |
(RefSeq) adenylate cyclase type 3 isoform X1
|
KO |
|
Organism |
ptr Pan troglodytes (chimpanzee)
|
Pathway |
ptr04072 | Phospholipase D signaling pathway |
ptr04213 | Longevity regulating pathway - multiple species |
ptr04261 | Adrenergic signaling in cardiomyocytes |
ptr04270 | Vascular smooth muscle contraction |
ptr04723 | Retrograde endocannabinoid signaling |
ptr04750 | Inflammatory mediator regulation of TRP channels |
ptr04914 | Progesterone-mediated oocyte maturation |
ptr04923 | Regulation of lipolysis in adipocytes |
ptr04925 | Aldosterone synthesis and secretion |
ptr04927 | Cortisol synthesis and secretion |
ptr04928 | Parathyroid hormone synthesis, secretion and action |
ptr04935 | Growth hormone synthesis, secretion and action |
ptr04962 | Vasopressin-regulated water reabsorption |
ptr05163 | Human cytomegalovirus infection |
ptr05166 | Human T-cell leukemia virus 1 infection |
ptr05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
KEGG Orthology (KO) [BR:ptr00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
459070 (ADCY3)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
459070 (ADCY3)
04371 Apelin signaling pathway
459070 (ADCY3)
04020 Calcium signaling pathway
459070 (ADCY3)
04072 Phospholipase D signaling pathway
459070 (ADCY3)
04024 cAMP signaling pathway
459070 (ADCY3)
04022 cGMP-PKG signaling pathway
459070 (ADCY3)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
459070 (ADCY3)
04081 Hormone signaling
459070 (ADCY3)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
459070 (ADCY3)
09144 Cellular community - eukaryotes
04540 Gap junction
459070 (ADCY3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
459070 (ADCY3)
04062 Chemokine signaling pathway
459070 (ADCY3)
09152 Endocrine system
04911 Insulin secretion
459070 (ADCY3)
04923 Regulation of lipolysis in adipocytes
459070 (ADCY3)
04912 GnRH signaling pathway
459070 (ADCY3)
04913 Ovarian steroidogenesis
459070 (ADCY3)
04915 Estrogen signaling pathway
459070 (ADCY3)
04914 Progesterone-mediated oocyte maturation
459070 (ADCY3)
04921 Oxytocin signaling pathway
459070 (ADCY3)
04926 Relaxin signaling pathway
459070 (ADCY3)
04935 Growth hormone synthesis, secretion and action
459070 (ADCY3)
04918 Thyroid hormone synthesis
459070 (ADCY3)
04928 Parathyroid hormone synthesis, secretion and action
459070 (ADCY3)
04916 Melanogenesis
459070 (ADCY3)
04925 Aldosterone synthesis and secretion
459070 (ADCY3)
04927 Cortisol synthesis and secretion
459070 (ADCY3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
459070 (ADCY3)
04270 Vascular smooth muscle contraction
459070 (ADCY3)
09154 Digestive system
04970 Salivary secretion
459070 (ADCY3)
04971 Gastric acid secretion
459070 (ADCY3)
04972 Pancreatic secretion
459070 (ADCY3)
04976 Bile secretion
459070 (ADCY3)
09155 Excretory system
04962 Vasopressin-regulated water reabsorption
459070 (ADCY3)
09156 Nervous system
04724 Glutamatergic synapse
459070 (ADCY3)
04727 GABAergic synapse
459070 (ADCY3)
04725 Cholinergic synapse
459070 (ADCY3)
04723 Retrograde endocannabinoid signaling
459070 (ADCY3)
09157 Sensory system
04740 Olfactory transduction
459070 (ADCY3)
04750 Inflammatory mediator regulation of TRP channels
459070 (ADCY3)
09149 Aging
04211 Longevity regulating pathway
459070 (ADCY3)
04213 Longevity regulating pathway - multiple species
459070 (ADCY3)
09159 Environmental adaptation
04713 Circadian entrainment
459070 (ADCY3)
04714 Thermogenesis
459070 (ADCY3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
459070 (ADCY3)
05207 Chemical carcinogenesis - receptor activation
459070 (ADCY3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
459070 (ADCY3)
05163 Human cytomegalovirus infection
459070 (ADCY3)
09165 Substance dependence
05032 Morphine addiction
459070 (ADCY3)
09166 Cardiovascular disease
05414 Dilated cardiomyopathy
459070 (ADCY3)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
459070 (ADCY3)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
459070 (ADCY3)
Enzymes [BR:ptr01000]
4. Lyases
4.6 Phosphorus-oxygen lyases
4.6.1 Phosphorus-oxygen lyases (only sub-subclass identified to date)
4.6.1.1 adenylate cyclase
459070 (ADCY3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
12:97952850..98053426
|
AA seq |
1145 aa
MPRNQGFSEPEYSAEYSAEYSVSLPSDPDRGVGRTHEISVRNSGSCLCLPRFMRLTFVPE
SLENLYQTYFKRQRHETLLVLVVFAALFDCYVVVMCAVVFSSDKLAPLAVAGIGLVLDII
LFVLCKKGLLPDRVTRRVVPYVLWLLITAQIFSYLGLNFARAHAASDTVGWQVFFVFSFF
ITLPLSLSPIVIISVVSCVVHTLVLGVTVAQQQQEELKGMQLLREILANVFLYLCAIAVG
IMSYYMADRKHRKAFLEARQSLEVKMNLEEQSQQQENLMLSILPKHVADEMLKDMKKDES
QKDQQQFNTMYMYRHENVSILFADIVGFTQLSSACSAQELVKLLNELFARFDKLAAKYHQ
LRIKILGDCYYCICGLPDYREDHAVCSILMGLAMVEAISYVREKTKTGVDMRVGVHTGTV
LGGVLGQKRWQYDVWSTDVTVANKMEAGGIPGRVHISQSTMDCLKGEFDVEPGDGGSRCD
YLEEKGIETYLIIASKPEVKKTATQNGLNGSALPNGAPASSKSSSPALIETKEPNGSAHS
SGSTSEKPEEQDAQADNPSFPNPRRRLRLQDLADRVVDASEDEHELNQLLNEALLERESA
QVVKKRNTFLLSMRFMDPEMETRYSVEKEKQSGAAFSCSCVVLLCTALVEILIDPWLMTN
YVTFMVGEILLLILTICSLAAIFPRAFPKKLVAFSTWIDRTRWARNTWAMLAIFILVMAN
VVDMLSCLQYYTGPGNATAGMETEGSCLENPKYYNYVAVLSLIATIMLVQVSHMVKLTLM
LLVAGAVATINLYAWRPVFDEYDHKRFREHDLPMVALEQMQGFNPGLNGTDSRLPLVPSK
YSMTVMVFLMMLSFYYFSRHVEKLARTLFLWKIEVHDQKERVYEMRRWNEALVTNMLPEH
VARHFLGSKKRDEELYSQTYDEIGVMFASLPNFADFYTEESINNGGIECLRFLNEIISDF
DSLLDNPKFRVITKIKTIGSTYMAASGVTPDVNTNGFASSNKEDKSERERWQHLADLADF
ALAMKDTLTNINNQSFNNFMLRIGMNKGGVLAGVIGARKPHYDIWGNTVNVASRMESTGV
MGNIQVVEETQVILREYGFRFVRRGPIFVKGKGELLTFFLKGRDKLATFPNGPSVTLPHQ
VVDNS |
NT seq |
3438 nt +upstreamnt +downstreamnt
atgccgaggaaccagggcttctccgagcccgaatactcggccgagtactcagccgagtac
tccgtcagcctgccctccgaccctgaccgcggggtgggccggacccatgaaatctcggtc
cggaactcgggctcctgcctgtgcctgcctcgctttatgcggctgactttcgtgccggag
tccttggagaacctctaccagacctacttcaaaaggcagcgccacgagaccctgctggtg
ctggtggtctttgcagccctctttgactgctacgtggtggtcatgtgtgctgtggtcttc
tccagcgacaagctggctcccctcgccgtggctggaattggactggtgttggacatcatc
ctcttcgtgctctgcaaaaaggggctgctcccggaccgggtcacccgcagagtggtgccc
tacgtgctgtggctgctcataaccgcccagatcttctcctacctgggcctgaacttcgcg
cgtgcccacgcggctagtgacacggtgggctggcaggtcttctttgtcttctccttcttc
atcacgctgcccctcagcctcagccccatcgtgatcatctccgtggtctcctgtgtggtg
cacacgttggtcctgggggtcaccgtggcccagcagcagcaggaggagctcaaggggatg
cagctgctgcgggagatcctggccaacgtcttcctctacctgtgcgccatcgctgtgggc
atcatgtcctactacatggctgaccgcaagcaccgcaaggccttcctggaggcccgccag
tcgctggaggtgaagatgaacctggaagagcagagccagcagcaggagaacctcatgctt
tccatcctgcccaagcacgtggctgacgagatgctgaaagacatgaagaaagacgagagc
cagaaggaccagcagcagttcaacaccatgtacatgtaccgtcacgagaacgtcagcatc
ctctttgccgacattgtgggctttactcagctgtcttctgcctgcagtgcccaggagctt
gtgaagctgctcaacgagctctttgcccgctttgacaagctggcagctaaataccaccag
ctgaggattaagatcctgggcgactgctactactgcatctgcggcttgcctgactaccgg
gaggaccacgccgtctgctccatcctcatggggctggccatggtggaggccatctcgtat
gtgcgggagaagaccaagactggggtggacatgcgtgtgggggtgcacacgggtaccgtg
ctggggggcgtcctgggccagaagcgctggcagtacgacgtgtggtcgactgatgtcact
gtagccaacaagatggaggccggcggcatccctgggcgcgtgcacatctcccagagcacc
atggactgcctgaaaggggagtttgatgtggagccaggcgatgggggcagccgctgtgat
tacctagaagagaagggtattgaaacctacctcatcattgcctccaagccagaggtgaag
aaaacagccacccagaatggcctcaatggctcggccctgcccaatggagcaccagcttcc
tcaaagtccagctcccctgccctcattgagaccaaggagcccaacgggagtgcccacagc
agcgggtccacgtcggagaagcccgaggagcaggatgcccaggccgacaacccctcattc
cccaacccacgccggaggctgcgcctgcaggacctggctgaccgagtggtggatgcctct
gaagatgagcacgagctcaaccagctgctcaacgaggccctgcttgagcgagagtccgcc
caagtagtaaagaagagaaacaccttcctcttgtccatgcggttcatggaccccgagatg
gaaacccgctactcggtggagaaggagaagcagagtggggctgccttcagctgctcctgc
gtcgtcctgctctgcacggccctggtcgagatactcatcgacccctggctaatgacaaac
tatgtgaccttcatggtgggggagattctgctcctcatcctgaccatctgctccctggct
gccatctttccccgggcctttcctaagaagcttgtggccttctcaacttggattgaccgg
acccgctgggccaggaacacctgggccatgctcgccatcttcatcctggtgatggcaaat
gtcgtggacatgctcagctgtctccagtactacacgggacccggcaatgcaacggcaggg
atggagacggagggcagctgcctggagaaccccaagtattacaactatgtggccgtgctg
tccctcatcgccaccatcatgctggtgcaggtcagccacatggtgaagctcacgctcatg
ctgctcgtcgcaggcgccgtggccaccatcaacctctatgcctggcgccccgtctttgat
gaatacgaccacaagcgttttcgggagcacgacttacctatggtggccttagagcagatg
caaggattcaaccctgggctcaatggcactgacagcaggctgcccctggtgccttccaag
tactctatgacggtgatggtgttcctcatgatgctcagcttctactacttctcccgccac
gtagaaaaactggcacggacacttttcttgtggaagattgaggtccacgaccagaaggaa
cgtgtttatgagatgcgacgctggaacgaggccttggtcaccaacatgttgcctgagcac
gtggcacgccatttcctggggtccaagaagagagatgaggagctgtatagccagacgtat
gatgagattggagtcatgtttgcctccctgcccaactttgctgacttctacacagaggag
agcatcaacaatggtggtattgagtgtctgcgtttcctcaatgaaatcatctcggatttt
gactctctcctggacaatcccaagttccgggtgatcaccaagatcaaaaccattggcagc
acgtatatggcggcttcaggagtcacccccgatgtcaacaccaatggctttgccagctcc
aacaaggaagacaagtccgagagagagcgctggcagcacctggctgacctggccgacttc
gcgctggccatgaaggatacgctcaccaacatcaacaaccagtccttcaataacttcatg
ctgcgcataggcatgaacaaaggcggggttctggctggggtcattggagcccggaaacca
cactacgacatctggggcaatacagtcaatgtagccagcaggatggagtccacgggggtc
atgggcaacattcaggtggtagaagaaacccaagtcatcctccgagagtacggcttccgc
tttgtgaggcgaggccccatctttgtgaaggggaagggggagctgctgaccttcttcttg
aaggggcgggataagctagccaccttccccaatggcccctctgtcacactgccccaccag
gtggtggacaactcctga |